Semenogelin I: A coagulum forming, multifunctional seminal vesicle protein

Cellular and Molecular Life Sciences

Volumn 55, Issue 6-7, 1999, Pages 944-960

  Robert, M ^a   Gagnon, C ^b  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Inhibin like peptides; Prostate specific antigen; REST gene; Seminal plasma; Seminal vesicle specific antigen; Sperm hyaluronidase; Sperm motility inhibitor

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; PROTEIN;

EJACULATION; GENE STRUCTURE; HUMAN; MALE; MULTIGENE FAMILY; NONHUMAN; PRIMATE; PROTEIN PURIFICATION; PROTEIN STRUCTURE; REVIEW; SEMINAL VESICLE; SPERMATOZOON MOTILITY;

EID: 0033016106     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050346     Document Type: Review

References (95)

1. 1 Tauber P. F. and Zaneveld L. J. (1981) Coagulation and Liquefaction of Human Semen. In: Biochemical Andrology, pp. 153-166, Hafez E. S. E. (ed.), Mosby, St. Louis
2. 2 Amelar R. D. (1962) Coagulation, liquefaction and viscosity of human semen. J. Urol. 87: 187-190
3. 3 Zaneveld L. J., Tauber P. F., Port C., Propping D. and Schumacher G. F. (1974) Scanning electron microscopy of the human, guinea-pig and rhesus monkey seminal coagulum. J. Reprod. Fertil. 40: 223-225
4. 4 Lilja H. and Laurell C. B. (1984) Liquefaction of coagulated human semen. Scand. J. Clin. Lab. Invest. 44: 447-452
5. 5 Lilja H. and Laurell C. B. (1985) The predominant protein in human seminal coagulate. Scand. J. Clin. Lab. Invest. 45: 635-641
6. 6 Chaistitvanich N. and Boonsaeng V. (1983) Molecular structure of human seminal coagulum: the role of disulfide bonds. Andrologia 15: 446-451
7. 7 Robert M. and Gagnon C. (1996) Purification and characterization of the active precursor of a human sperm motility inhibitor secreted by the seminal vesicles: identity with semenogelin. Biol. Reprod. 55: 813-821
8. 8 Mandal A. and Bhattacharyya A. K. (1995) Sperm hyaluronidase activation by purified predominant and major basic human seminal coagulum proteins. Hum. Reprod. 10: 1745-1750
9. 9 Lilja H., Laurell C. B. and Jeppsson J. O. (1984) Characterization of the predominant basic protein in human seminal plasma, one cleavage product of the major seminal vesicle protein. Scand. J. Clin. Lab. Invest. 44: 439-446
10. 10 Lilja H. (1985) A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J. Clin. Invest. 76: 1899-1903
11. 11 Lilja H. and Weiber H. (1984) Synthetic protease inhibitors and post-ejaculatory degradation of human semen proteins. Scand. J. Clin. Lab. Invest. 44: 433-438
12. 12 Lilja H., Oldbring J., Rannevik G. and Laurell C. B. (1987) Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen. J. Clin. Invest. 80: 281-285
13. 13 Lilja H., Abrahamsson P. A. and Lundwall A. (1989) Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa. J. Biol. Chem. 264: 1894-1900
14. 14 Li C. H., Hammonds R. G. Jr., Ramasharma K. and Chung D. (1985) Human seminal alpha inhibins: isolation, characterization and structure. Proc. Natl. Acad. Sci. USA 82: 4041-4044
15. 15 Schneider K., Kausler W., Tripier D., Jouverial K. and Spiteller G. (1989) Isolation and structure determination of two peptides occurring in human seminal plasma. Biol. Chem. Hoppe Seyler 370: 353-356
16. 16 Lilja H. (1990) Cell biology of semenogelin. Andrologia 22: I32-141
17. 17 Lindemann C. B. and Gibbons I. R. (1975) Adenosine triphosphate-induced motility and sliding of filaments in mammalian sperm extracted with Triton X-100. J. Cell Biol. 65: 147-162
18. 18 Mohri H. and Yanagimachi R. (1980) Characteristics of motor apparatus in testicular, epididymal and ejaculated spermatozoa. A study using demembranated sperm models. Exp. Cell Res. 127: 191-196
19. 19 de Lamirande E., Bardin C. W. and Gagnon C. (1983) Aprotinin and a seminal plasma factor inhibit the motility of demembranated reactivated rabbit spermatozoa. Biol. Reprod. 28: 788-796
20. 20 de Lamirande E. and Gagnon C. (1983) Aprotinin and a seminal plasma factor provide two new tools to study the regulation of sperm motility. J. Submicrosc. Cytol. 15: 83-87
21. 21 Iwamoto T. and Gagnon C. (1988) Purification and characterization of a sperm motility inhibitor in human seminal plasma. J. Androl. 9: 377-383
22. 22 Iwamoto T. and Gagnon C. (1988) A human seminal plasma protein blocks the molility of human spermatozoa. J. Urol. 140: 1045-1048
23. 23 Luterman M., Iwamoto T. and Gagnon C. (1991) Origin of the human seminal plasma motility inhibitor within the reproductive tract. Int. J. Androl. 14: 91-98
24. 24 Robert M. and Gagnon C. (1994) Sperm motility inhibitor from human seminal plasma: presence of a precursor molecule in seminal vesicle fluid and its molecular processing after ejaculation. Int. J. Androl. 17: 232-240
25. 25 Robert M. and Gagnon C. (1995) Sperm molility inhibitor from human seminal plasma: association with semen coagulum. Hum. Reprod. 10: 2192-2197
26. 26 Lilja H. and Lundwall A. (1992) Molecular cloning of epididymal and seminal vesicular transcripts encoding a semenogelin-related protein. Proc. Natl. Acad. Sci. USA 89: 4559-4563
27. 27 Malm J., Hellman J., Magnusson H., Laurell C. B. and Lilja H. (1996) Isolation and characterization of the major gel proteins in human semen, semenogelin I and semenogelin II. Eur. J. Biochem. 238: 48-53
28. 28 Ulvsback M., Lazure C., Lilja H., Spurr N. K., Rao V. V., Loffler C. et al. (1992) Gene structure of semenogelin I and II. The predominant proteins in human semen are encoded by two homologous genes on chromosome 20. J. Biol. Chem. 267: 18080-18084
29. 29 Lundwall A. (1996) The structure of the semenogelin gene locus nucleotide sequence of the intergenie and the flanking DNA. Eur. J. Biochem. 235: 466-470
30. 30 Lundwall A. and Lazure C. (1995) A novel gene family encoding proteins with highly differing structure because of a rapidly evolving exon. FEBS Lett. 374: 53-56
31. 31 Aumuller G., Seitz J., Lilja H., Abrahamsson P. A., von der Kammer H. and Scheit K. H. (1990) Species- and organ-specificity of secretory proteins derived from human prostate and seminal vesicles. Prostate 17: 31-40
32. 32 Ulvsback M. and Lundwall A. (1997) Cloning of the semenogelin II gene of the rhesus monkey. Duplications of 360 bp extend the coding region in man, rhesus mon key and baboon. Eur. J. Biochem. 245: 25-31
33. 33 Lundwall A. (1998) The cotton-top tamarin carries an extended semenogelin I gene but no semenogelin II gene. Eur. J. Biochem. 255: 45-51
34. 34 Bjartell A., Malm J., Moller C., Gunnarsson M., Lundwell A. and Lilja H. (1996) Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immunocytochemistry. J. Androl. 17: 17-26
35. 35 Luke M. C. and Coffey D. S. (1994) Human androgen receptor binding to the androgen response element of prostate specific antigen. J. Androl. 15: 41-51
36. 36 Mandal A. and Bhattacharyya A. K. (1994) Isolation of the predominant coagulum protein of human semen before liquefaction. Hum. Reprod. 9: 320-324
37. 37 Robert M., Gibbs B. F., Jacobson E. and Gagnon C. (1997) Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motilily inhibitor precursor/semenogelin I. Biochemistry 36: 3811-3819
38. 38 Herr J. C., Summers T. A., McGee R. S., Sutherland W. M., Sigman M. and Evans R. J. (1986) Characterization of a monoclonal antibody to a conserved epitope on human seminal vesicle-specific peptides: a novel probe/marker system for semen identification. Biol. Reprod. 35: 773-784
39. 39 McGee R. S. and Herr J. C. (1987) Human seminal vesicle-specific antigen during semen liquefaction. Biol. Reprod. 37: 431-439
40. 40 McGee R. S. and Herr J. C. (1988) Human seminal vesicle-specific antigen is a substrate for prostate specific antigen (or P-30). Biol. Reprod. 39: 499-510
41. 41 Herr J. C., Conklin D. J. and McGee R. S. (1989) Purification of low molecular weight forms of seminal vesicle specific antigen by immunoaffinity chromatography on bound monoclonal antibody MHS-5. J. Reprod. Immunol. 16: 99-113
42. 42 Lynch M. J., Masters J., Pryor J. P., Lindon J. C., Spraul M., Foxall P. J. et al. (1994) Ultra high field NMR spectroscopic studies on human seminal fluid, seminal vesicle and prostatic secretions. J. Pharm. Biomed. Anal. 12: 5-19
43. 43 Mandal A. and Bhattacharyya A. K. (1990) Biochemical composition of washed human seminal coagulum in comparison to sperm-free semen from the same donors. J. Reprod. Fertil. 88: 113-118
44. 44 Frenette G., Tremblay R. R. and Dube J. Y. (1989) Zinc binding to major human seminal coagulum proteins. Arch. Androl. 23: 155-163
45. 45 Peter A., Lilja H., Lundwall A. and Malm J. (1998) Semenogelin I and semenogelin II, the major gel-forming proteins in human semen, are substrates for transglutaminase. Eur. J. Biochem. 252: 216-221
46. 46 Grant F. J., Taylor D. A., Sheppard P. O., Mathewes S. L., Lint W., Vanaja E. et al. (1994) Molecular cloning and characterization of a novel transglutaminase cDNA from a human prostate cDNA library. Biochem. Biophys. Res. Commun. 203: 1117-1123
47. 47 Akiyama K., Nakamura T., Iwanaga S. and Hara M. (1987) The chymotrypsin-like activity of human prostate specific antigen, gamma-seminoprotein. FEBS Lett. 225: 168-172
48. 48 Watt K. W., Lee P. J., M'Timkulu T., Chan W. P. and Loor R. (1986) Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc. Natl. Acad. Sci. USA 83: 3166-3170
49. 49 Denmeade S. R., Lou W., Lovgren J., Malm J., Lilja H. and Isaacs J. T. (1997) Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen. Cancer Res. 57: 4924-4930
50. 50 Coombs G. S., Bergstrom R. C., Pellequer J. L., Baker S, I., Navre M., Smith M. M. et al. (1998) Substrate specificity of prostate-specific antigen (PSA). Chem. Biol. 5: 475-488
51. 51 Lundwall A. and Lilja H. (1987) Molecular cloning of human prostate specific antigen cDNA. FEBS Lett. 214: 317-322
52. 52 Vihinen M. (1994) Modeling of prostate specific antigen and human glandular kallikrein structures. Biochem. Biophys. Res. Commun. 204: 1251-1256
53. 53 Christensson A. and Lilja H. (1994) Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. Eur. J. Biochem. 220: 45-53
54. 54 Kise H., Nishioka J., Kawamura J. and Suzuki K. (1996) Characterization of semenogelin II and its molecular interaction with prostate-specific antigen and protein C inhibitor. Eur. J. Biochem. 238: 88-96
55. 55 Paradis G., Tremblay R. R. and Dube J. Y. (1989) Looking for human glandular kallikrein-1 in the prostate. Prostate 15: 343-353
56. 56 Deperthes D., Chapdelaine P., Tremblay R. R., Brunet C., Berton J., Hebert J. et al. (1995) Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma. Biochim. Biophys. Acta 1245: 311-316
57. 57 Yu J. X., Chao L. and Chao J. (1994) Prostasin is a novel human serine proteinase from seminal fluid. Purification, tissue distribution, and localization in prostate gland. J. Biol. Chem. 269: 18843-18848
58. 58 Deperthes D., Frenette G., Brillard-Bourdet M., Bourgeois L., Gauthier F., Tremblay R. R. et al. (1996) Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation. J. Androl. 17: 659-665
59. 59 Lilja H. and Jeppsson J. O. (1985) Amino acid sequence of the predominant basic protein in human seminal plasma. FEBS Lett. 182: 181-184
60. 60 Kausler W. and Spiteller G. (1992) Analysis of peptides of human seminal plasma by mass spectrometry. Biol. Mass Spectrom. 21: 567-575
61. 61 Mann T. and Lutwak-Mann C. (1981) Male Reproductive Function and Semen. Themes and Trends in Physiology, Biochemistry and Investigative Andrology, Springer, Berlin
62. 62 Aumuller G. and Seitz J. (1990) Protein secretion and secretory processes in male accessory sex glands. Int. Rev. Cytol. 121: 127-231
63. 63 Williams-Ashman H. G. (1984) Transglutaminases and the clotting of mammalian seminal fluids. Mol. Cell. Biochem. 58: 51-61
64. 64 Lukae J. and Koren E. (1979) Mechanism of liquefaction of the human ejaculate. II. Role of collagenase-like peptidase and seminal proteinase. J. Reprod. Fertil. 56: 501-506
65. 65 Polak B. and Daunter B. (1989) Seminal plasma biochemistry. IV: Enzymes involved in the liquefaction of human seminal plasma. Int. J. Androl. 12: 187-194
66. 66 Polak B. and Daunter B. (1990) Seminal plasma biochemistry. III: Characterization of coagulum components. Eur. J. Obstet. Gynecol. Reprod. Biol. 35: 223-234
67. 67 Montagnon D., Valtat B., Vignon F. and Koll-Back M. H. (1990) Secretory proteins of human seminal vesicles and their relationship to lipids and sugars. Andrologia 22 (Suppl. 1): 193-205
68. 68 Boonsaeng V. (1986) Molecular structure of human seminal coagulum: the role of proteolysis. Andrologia 18: 252-258
69. 69 Lee C., Keefer M., Zhao Z. W., Kroes R., Berg L., Liu X. X. et al. (1989) Demonstration of the role of prostate-specific antigen in semen liquefaction by two-dimensional electrophoresis. J. Androl. 10: 432-438
70. 70 Hisazumi H. (1970) Studies on the fibrinolytic activity in human semen studied by gel filtration. Invest. Urol. 7: 410-421
71. 71 Flickinger C. J., Herr J. C., McGee R. S., Sigman M., Evans R. J., Sutherland W. M. et al. (1990) Dynamics of a human seminal vesicle specific protein. Andrologia 22: 142-154
72. 72 Khan Z., and Smyth D. G. (1993) Isolation and identification of N-terminally extended forms of 5-oxoprolylglutamylprolinamide (Glp-Glu-Pro-NH2), a thyrotropin-releasing-hormone (TRH)-like peptide present in human semen. Eur. J. Biochem. 212: 35-40
73. 73 Schaller J., Akiyama K., Tsuda R., Hara M., Marti T. and Rickli E. E. (1987) Isolation, characterization and amino-acid sequence of gamma-seminoprotein, a glycoprotein from human seminal plasma. Eur. J. Biochem. 170: 111-120
74. 74 Daunter B., Hill R., Hennessey J. and Mackay E. V. (1981) Seminal plasma biochemistry. I. Preliminary report: a possible mechanism for the liquefaction of human seminal plasma and its relationship to spermatozoal motility. Andrologia 13: 131-141
75. 75 Ramasharma K. and Li C. H. (1987) Characteristics of binding of human seminal alpha-inhibin-92 to human pituitary membranes, Proc. Natl. Acad. Sci. USA 84: 3595-3598
76. 76 Desnoyers L. and Manjunath P. (1992) Major proteins of bovine seminal plasma exhibit novel interactions with phospholipid. J. Biol. Chem. 267: 10149-10155
77. 77 Dostalova Z., Calvete J. J. and Topfer-Petersen E. (1995) Interaction of non-aggregated boar AWN-1 and AQN-3 with phospholipid matrices. A model for coating of spermadhesins to the sperm surface. Biol. Chem. Hoppe Seyler 376; 237-242
78. 78 Ensslin M., Calvete J. J., Thole H. H., Sierralta W. D., Adermann K., Sanz L et al. (1995) Identification by affinity chromatography of boar sperm membrane-associated proteins bound to immobilized porcine zona pellucida. Mapping of the phosphorylethanolamine-binding region of spermadhesin AWN. Biol. Chem. Hoppe Seyler 376: 733-738
79. 79 Iwamoto T., Hiroaki H., Furuichi Y., Wada K., Satoh M., Osada T. et al. (1995) Cloning of boar SPMI gene which is expressed specifically in seminal vesicle and codes for a sperm motility inhibitor protein. FEBS Lett. 368: 420-424
80. 80 Iwamoto T., Tsang A., Luterman M., Dickson J., de Lamirande E., Okuno M. et al. (1992) Purification and characterization of a sperm motility-dynein ATPase inhibitor from boar seminal plasma. Mol. Reprod. Dev. 31: 55-62
81. 81 D'Cruz O. J., Pereira H. A. and Haas G. G. Jr. (1995) Sperm immobilizing activity of a synthetic bioactive peptide 20 44 of 37-kDa cationic antimicrobial protein (CAP37) of human neutrophils. J. Androl. 16: 432-440
82. 82 Zalensky A. O., Yau P., Breneman J. W. and Bradbury E. M. (1993) The abundant 19-kilodalton protein associated with human sperm nuclei that is related to seminal plasma alpha-inhibins. Mol. Reprod. Dev. 36: 164-173
83. 83 de Lamirande E., Sherins R. J. and Gagnon C. (1986) The presence of a motility inhibitor within spermatozoa may explain the poor sperm motility of some infertile men. J. Androl. 7: 215-219
84. 84 Clements J. A. (1989) The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation. Endocr. Rev. 10: 393-419
85. 85 Huber A. E., Fraser H., del Rio-Garcia J., Kreil G. and Smyth D. G. (1998) Molecular cloning in the marmoset shows that semenogelin is not the precursor of the TRH-like peptide pGlu-Glu-Pro amide. Biochim. Biophys. Acta 1387: 143-152
86. 86 Fichtner J., Graves H. C., Thatcher K., Yemoto C. and Shortliffe L. M. (1996) Prostate specific antigen releases a kinin-like substance on proteolysis of seminal vesicle fluid that stimulates smooth muscle contraction. J. Urol. 155: 738-742
87. 87 Kjellberg S., Bjorndahl L. and Kvist U. (1992) Sperm chromatin stability and zinc binding properties in semen from men in barren unions. Int. J. Androl. 15: 103-113
88. 88 Kvist U., Kjellberg S., Bjorndahl L., Soufir J. C. and Arver S. (1990) Seminal fluid from men with agenesis of the Wolffian ducts: zinc-binding properties and effects on sperm chromatin stability. Int. J. Androl. 13: 245-252
89. 89 Herr J. C. and Woodward M. P. (1987) An enzyme-linked immunosorbent assay (ELISA) for human semen identification based on a biotinylated monoclonal antibody to a seminal vesicle-specific antigen. J. Forensic Sci. 32: 346-356
90. 90 Keil W., Bachus J. and Troger H. D. (1996) Evaluation of MHS-5 in detecting seminal fluid in vaginal swabs. Int. J. Legal Med. 108: 186-190
91. 91 Calderon I., Barak M., Abramovici H., Gruener N., Yavez H., Paz G. et al. (1994) The use of a seminal vesicle specific protein (MHS-5 antigen) for diagnosis of agenesis of vas deferens and seminal vesicles in azoospermic men. J. Androl. 15: 603-607
92. 92 Denmeade S. R., Nagy A., Gao J., Lilja H., Schally A. V. and Isaacs J. T. (1998) Enzymatic activation of a doxorubicin-peptide prodrug by prostate-specific antigen. Cancer Res. 58: 2537-2540
93. 93 Hagstrom J. E., Fautsch M. P., Perdok M., Vrabel A. and Wieben E. D. (1996) Exons lost and found. Unusual evolution of a seminal vesicle transglutaminase substrate. J. Biol. Chem. 271: 21114-21119
94. 94 Lundwall A. (1996) The cloning of a rapidly evolving seminal-vesicle-transcribed gene encoding the major clot-forming protein of mouse semen. Eur. J. Biochem. 235: 424-430
95. 95 Ramasharma K., Sairam M. R., Seidah N. G., Chretien M., Manjunath P., Schiller P. W. et al. (1984) Isolation, structure and synthesis of a human seminal plasma peptide with inhibin-like activity. Science 223: 1199-1202